Phio Pharmaceuticals (PHIO) Expected to Announce Earnings on Monday

Phio Pharmaceuticals (NASDAQ:PHIO) is expected to release its earnings data on Monday, March 24th. Analysts expect Phio Pharmaceuticals to post earnings of ($1.23) per share for the quarter.

Phio Pharmaceuticals Price Performance

NASDAQ PHIO opened at $1.29 on Friday. The stock’s fifty day moving average price is $1.93 and its 200 day moving average price is $2.46. Phio Pharmaceuticals has a 1 year low of $1.22 and a 1 year high of $9.79. The company has a market cap of $8.89 million, a price-to-earnings ratio of -0.12 and a beta of 1.28.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $4.00 price target on shares of Phio Pharmaceuticals in a report on Wednesday, February 19th.

About Phio Pharmaceuticals

Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells’ ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors.